254 related articles for article (PubMed ID: 8395567)
1. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from 7315c cell membranes.
Cote TE; Gosse ME; Weems HB
J Neurochem; 1993 Sep; 61(3):973-8. PubMed ID: 8395567
[TBL] [Abstract][Full Text] [Related]
2. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
Weems HB; Chalecka-Franaszek E; Côté TE
J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
[TBL] [Abstract][Full Text] [Related]
3. Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding.
Ofri D; Ritter AM; Liu YF; Gioannini TL; Hiller JM; Simon EJ
J Neurochem; 1992 Feb; 58(2):628-35. PubMed ID: 1309566
[TBL] [Abstract][Full Text] [Related]
4. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
5. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
6. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
7. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
8. Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3).
Chalecka-Franaszek E; Weems HB; Crowder AT; Cox BM; Côté TE
J Neurochem; 2000 Mar; 74(3):1068-78. PubMed ID: 10693938
[TBL] [Abstract][Full Text] [Related]
9. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
Werling LL; Puttfarcken PS; Cox BM
Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
[TBL] [Abstract][Full Text] [Related]
10. The mu-opioid receptor in the 7315c tumor cell.
Tocque B; Jacobson AE; Rice KC; Frey EA
Eur J Pharmacol; 1987 Nov; 143(1):127-30. PubMed ID: 2826184
[TBL] [Abstract][Full Text] [Related]
11. Characterization of opioid receptors in cultured neurons.
Vaysse PJ; Zukin RS; Fields KL; Kessler JA
J Neurochem; 1990 Aug; 55(2):624-31. PubMed ID: 2164573
[TBL] [Abstract][Full Text] [Related]
12. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
Wang WW; Shahrestanifar M; Jin J; Howells RD
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
[TBL] [Abstract][Full Text] [Related]
13. Dog cerebral cortex contains mu-, delta- and kappa-opioid receptors at different densities: apparent lack of evidence for subtypes of the kappa-receptor using selective radioligands.
Sharif NA; Durie E; Michel AD; Whiting RL
Brain Res; 1990 Feb; 510(1):108-14. PubMed ID: 2157522
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
15. Immunoprecipitation of opioid receptor-Go-protein complexes using specific GTP-binding-protein antisera.
Georgoussi Z; Milligan G; Zioudrou C
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):71-5. PubMed ID: 7864831
[TBL] [Abstract][Full Text] [Related]
16. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
17. Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides.
Cruciani RA; Dvorkin B; Klinger HP; Makman MH
Brain Res; 1994 Dec; 667(2):229-37. PubMed ID: 7697360
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
Breivogel CS; Selley DE; Childers SR
J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
[TBL] [Abstract][Full Text] [Related]
19. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
Delay-Goyet P; Roques BP; Zajac JM
Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
Côté TE; Izenwasser S; Weems HB
J Pharmacol Exp Ther; 1993 Oct; 267(1):238-44. PubMed ID: 8229750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
